Published in Obesity and Diabetes Week, April 6th, 2009
This report provides a detailed analysis on the adverse events reported in the FDA AERS database, for the prescribed Thiazolidone derivatives namely Avandia, Actos, Avandamet and Avandaryl, along with Incretins which include Januvia and Byetta, all approved for the treatment of Type II Diabetes Mellitus. It provides a statistical analysis of these leading anti-diabetic therapeutics, from real-time data that includes cases, adverse events, reactions and outcomes, associated with...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Obesity and Diabetes Week